| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20048099 | HPV | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS20047857 | HPV | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS20048199 | HPV | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS20036026 | HPV | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS44028965 | HTLV-1 | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS44032561 | HTLV-1 | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS44011963 | HTLV-1 | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS44037440 | HTLV-1 | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS44037071 | HTLV-1 | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
| TVIS44037061 | HTLV-1 | ENSG00000198626.19 | protein_coding | RYR2 | No | No | 6262 | Q92736 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | RYR2 |
|---|---|
| DrugBank ID | DB09085 |
| Drug Name | Tetracaine |
| Target ID | BE0005295 |
| UniProt ID | Q92736 |
| Regulation Type | modulator |
| PubMed IDs | 21624373; 20961976 |
| Citations | Laver DR, van Helden DF: Three independent mechanisms contribute to tetracaine inhibition of cardiac calcium release channels. J Mol Cell Cardiol. 2011 Sep;51(3):357-69. doi: 10.1016/j.yjmcc.2011.05.009. Epub 2011 May 19.@@Lanner JT, Georgiou DK, Joshi AD, Hamilton SL: Ryanodine receptors: structure, expression, molecular details, and function in calcium release. Cold Spring Harb Perspect Biol. 2010 Nov;2(11):a003996. doi: 10.1101/cshperspect.a003996. Epub 2010 Oct 20. |
| Groups | Approved; Vet_approved |
| Direct Classification | Benzoic acid esters |
| SMILES | CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C |
| Pathways | |
| PharmGKB | PA451638 |
| ChEMBL | CHEMBL698 |
